Repeated Subcutaneous Administration of ABvac40 in Mild to Moderate Alzheimer's Disease Patients
Clinical trial NCT03113812 · COMPLETED
Trial details
- NCT number
- NCT03113812
- Sponsor
- Araclon Biotech S.L.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2015-07-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.